Scott E. Kern
- Oncology top 0.02%
- Pancreatic and Hepatic Oncology Research 83
- Cancer-related Molecular Pathways 19
- Cancer Research top 0.05%
- Cancer Genomics and Diagnostics 49
- Pathology and Forensic Medicine top 0.02%
- Genetic factors in colorectal cancer 37
- Molecular Biology top 0.1%
- Epigenetics and DNA Methylation 25
- DNA Repair Mechanisms 14
- TGF-β signaling in diseases 14
- Biotechnology top 0.1%
-
- BRCA gene mutations in cancer 14
- Co-authors
- Bert VogelsteinRalph H. HrubanKenneth W. KinzlerStanley R. HamiltonEric R. FearonCharles J. YeoJohannes L. BosAlida M.M. Smits
- Journals
- Cancer Biology & Therapy (22 papers)American Journal Of Pathology (14 papers)Cancer Research (11 papers)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Scott E. Kern
174 papers receiving 31.0k citations
Hit Papers
Peers
Comparison fields: 5 of 176
- Oncology 19.0k
- Cancer Research 8.5k
- Pathology and Forensic Medicine 7.9k
- Molecular Biology 16.5k
- Biotechnology 1.5k
Countries citing papers authored by Scott E. Kern
This map shows the geographic impact of Scott E. Kern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott E. Kern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott E. Kern more than expected).
Fields of papers citing papers by Scott E. Kern
This network shows the impact of papers produced by Scott E. Kern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott E. Kern. The network helps show where Scott E. Kern may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Scott E. Kern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 29 | |
| 2 | 2013 | 19 | |
| 3 | 2007 | 77 | |
| 4 | 2007 | 148 | |
| 5 | 2006 | 66 | |
| 6 | 2006 | 39 | |
| 7 | 2004 | 93 | |
| 8 | 2003 | 394 | |
| 9 | 2002 | 241 | |
| 10 | 2002 | 172 | |
| 11 | Pancreatic Intraepithelial Neoplasiabreakdown → | 2001 | 842 |
| 12 | 2000 | 159 | |
| 13 | 2000 | 26 | |
| 14 | 2000 | 178 | |
| 15 | 1999 | 74 | |
| 16 | 1999 | 303 | |
| 17 | Two active copies of the X-linked gene spermidine/spermine N1-acetyltransferase (SSAT) in a female lung cancer cell line are associated with an increase in sensitivity to an antitumor polyamine analogue. | 1998 | 20 |
| 18 | 1998 | 36 | |
| 19 | 1996 | 150 | |
| 20 | Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancersbreakdown → | 1996 | 501 |
About Scott E. Kern
Scott E. Kern is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 174 papers that have together received 31.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (83 papers), Cancer Genomics and Diagnostics (49 papers), Genetic factors in colorectal cancer (37 papers), Epigenetics and DNA Methylation (25 papers), Cancer-related Molecular Pathways (19 papers), DNA Repair Mechanisms (14 papers), BRCA gene mutations in cancer (14 papers) and TGF-β signaling in diseases (14 papers). The work is most often cited by research in Oncology (19.0k citations), Cancer Research (8.5k citations) and Pathology and Forensic Medicine (7.9k citations). Scott E. Kern has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Bert Vogelstein, Ralph H. Hruban, Kenneth W. Kinzler, Stanley R. Hamilton, Eric R. Fearon, Charles J. Yeo, Johannes L. Bos, Alida M.M. Smits, Mark Leppert and Michael Goggins. Their work appears in journals such as Cancer Biology & Therapy, American Journal Of Pathology, Cancer Research, Genes Chromosomes and Cancer and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.